Literature DB >> 1839774

Epidemiology and social costs of low back pain and fibromyalgia.

G de Girolamo1.   

Abstract

Low back pain and fibromyalgia represent two of the most common disorders in developed countries. On the whole, up to 75% of the general population has, at some time, suffered from low back pain. A percentage ranging between 5 and 10% of them develops a chronic illness. In most countries, the incidence rate per year of low back pain is 5%. Most low back pain episodes occur between the ages of 25 and 55 years. Most studies have not found any clear influence between genders and frequency of low back pain. There is a relationship between low back pain and occupation, with those who have physically demanding jobs being more at risk. As regards fibromyalgia, the prevalence rates range between 6 and 20%, with a higher frequency among females and between the ages of 25 and 55 years. The direct and indirect costs of low back pain approach $24 billion per year in the U.S. It is in view of its high prevalence among populations of developed countries, of its heavy psychosocial and financial implications, and of the burden imposed on health services, that low back pain represents a severe public health problem.

Entities:  

Mesh:

Year:  1991        PMID: 1839774

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  7 in total

Review 1.  Pharmacoeconomics of chronic nonmalignant pain.

Authors:  M J Zagari; P D Mazonson; W C Longton
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

2.  A clinical return-to-work rule for patients with back pain.

Authors:  Clermont E Dionne; Renée Bourbonnais; Pierre Frémont; Michel Rossignol; Susan R Stock; Isabelle Larocque
Journal:  CMAJ       Date:  2005-06-07       Impact factor: 8.262

3.  Role of nociceptor αCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats.

Authors:  Luiz F Ferrari; Oliver Bogen; Jon D Levine
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

4.  Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.

Authors:  Nicole M Marlow; Kit N Simpson; Ivana A Vaughn; Ara Jo; James S Zoller; Edward B Short
Journal:  Pain Pract       Date:  2017-05-28       Impact factor: 3.183

5.  [Analysis of the cost of illness in backache].

Authors:  W Bolten; A Kempel-Waibel; W Pförringer
Journal:  Med Klin (Munich)       Date:  1998-06-15

Review 6.  The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Alireza Amir Maafi; Babak Ghalebaghi
Journal:  Korean J Pain       Date:  2015-07-01

7.  Whiplash Syndrome Reloaded: Digital Echoes of Whiplash Syndrome in the European Internet Search Engine Context.

Authors:  Michael Noll-Hussong
Journal:  JMIR Public Health Surveill       Date:  2017-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.